Xenoview for pulmonary imaging
Name: Xenoview Active Ingredient: hyperpolarized Xe-129 Indications: To evaluate pulmonary function and imaging Approval Date: 12/23/2022 Company: Polarean, Inc. Learn more: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214375s000lbl.pdf